25+
Years of Ophthalmology Experience & Leadership
Fortune 500
Former VP, Head of Retinal Discovery at J&J
Tenured NIH
Former Senior Investigator and Clinician at National Eye Institute
>17K
Citations | h-index 70 |
>160 Publications
Strategic Advisory Pillars
Target & Platform Validation
De-risking and prioritizing novel therapeutic targets utilizing optimal drug delivery platforms
End-to-End
Strategy
Guiding clients smoothly through the operational and strategic transition from preclinical IND-enabling studies to Phase 1/2/3 trial design.
Investment Strategy & Due Diligence
Providing expert competitive landscaping, asset evaluations, and scientific pitch deck development for capital and licensing rounds
Biotech & Emerging Startups
Strategic guidance to accelerate early-stage programs from pre-clinical discovery through successful IND-enabling studies.
Optimizing scientific narratives and pitch decks to maximize impact for Series A/B/C and licensing rounds.
Global Pharmaceutical Companies
Elite subject matter expertise to bridge the gap between complex bench science and commercial success.
Advising on novel target and platform validation, clinical trial design, and high-impact medical/regulatory positioning.
Venture Capital &
Investors
Independent scientific and clinical due diligence to de-risk high-value investments.
Providing objective asset evaluations, quantitative clinical data analysis, and competitive landscaping for potential pipeline acquisitions.
Who We Serve: Our Client Record
Translational Science & Key Publications
JAMA Ophthalmology (2024)
Phase 2 Trial evaluating Minocycline for Geographic Atrophy in Age-Related Macular Degeneration.
Nature Reviews Disease Primers (2021)
Landmark global consensus and strategic review on the pathogenesis and management of Age-Related Macular Degeneration.
Annual Reviews of Vision Science (2018)
Review summarizing groundbreaking translational research establishing the role of microglia and neuroinflammation in retinal disease architecture.
Elife (2024)
Original research on the integration of human iPSC-derived microglia into the mouse retina as POC demonstration of microglia transplantation into the retina as a therapeutic approach.
US Patent (filed 2021)
"Methods and systems
for predicting rates of progression of age-related macular degeneration" AI/DL-based analysis of fundus images from landmark AREDS/2 studies.
Align Your Pipeline with Elite Strategic Insight
Inquire about principal availability for strategic biopharma consulting, scientific advisory board placement, or institutional asset due diligence.